OART is increasingly emerging to assess and adapt treatment for cancer patients
The Royal Marsden NHS Foundation Trust is set to implement online adaptive radiation therapy (OART) with RaySearch’s treatment planning system, RayStation, and oncology information system, RayCare.
OART is a novel treatment for cancer patients that is increasingly emerging to assess patients’ anatomy, with a treatment plan adapted from an original reference plan with the patient on the treatment couch.
The Royal Marsden has been using RayStation for conventional treatment planning since 2016 and most recently acquired two additional Radixact treatment delivery machines from Accuray to be used for OART.
Daily-acquired patient images are used by OART to optimise treatment plans by considering the changes in the patients’ anatomy.
OART puts high demand on the acquired images and an efficient information flow between the treatment planning system, the oncology information system and the treatment control system.
RaySearch and Accuray’s ARTemis aim to provide online adaptive solutions for clinicians who use RayStation’s treatment planning system with the Radixact treatment delivery system.
The Royal Marsden will utilise RaySearch’s workflow management tools and Accuray’s ClearRTTM imaging for online adaptive therapy by implementing the full ARTemis package, which has been funded by the Royal Marsden Cancer Charity.
Johan Löf, founder and chief executive officer of RaySearch, said: “The tools have been available in RayStation for many years and RayCare has, from the beginning, been developed to facilitate the implementation of OART in clinical routine.”
The trust aims to become the first centre in the world to regularly perform OART on patients treated on the Radixact System.
Professor Uwe Oelfke, head of the joint department of physics at the Royal Marsden and the Institute of Cancer Research, said: “The ARTemis platform will enable us to tailor treatment in real time for patients being treated on our two new Radixact machines,… allowing us to target… disease more precisely and reduce damage to healthy tissue.”

https://pham.com/news/royal-marsden-to-implement-raysearchs-online-adaptive-radiation-therapy-system/